Drug intelligence / Profile preview

difenpiramide

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Difenpiramide is a non-steroidal anti-inflammatory drug (NSAID) belonging to the acetic acid derivatives class. It is a monocarboxylic acid amide formed by the condensation of biphenyl-4-ylacetic acid and 2-aminopyridine. Difenpiramide has been used primarily for the treatment of musculoskeletal and joint disorders, including rheumatoid arthritis and osteoarthritis. Its pharmacological actions include anti-inflammatory, analgesic (non-narcotic), antipyretic, and uricosuric effects. The drug acts mainly by inhibiting cyclooxygenase (COX), thereby blocking prostaglandin synthesis involved in inflammation, pain, and fever. Unlike many NSAIDs, difenpiramide does not significantly affect platelet aggregation or blood clotting. Clinical studies have shown it to be effective with a favorable safety profile; gastrointestinal side effects are rare and generally mild[1][3][4][5][6].

Brand names
Difenax
Other names
diphenpyramide2-([1,1'-biphenyl]-4-yl)-N-(pyridin-2-yl)acetamide
02

Targets

COX

Beyond the preview

Go deeper on difenpiramide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on difenpiramide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call